Advertisement
BAX vs NHNKY
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a StrongBuy and NHNKY is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BAX’s FA Score shows that 2 FA rating(s) are green whileNHNKY’s FA Score has 2 green FA rating(s).
- BAX’s FA Score: 2 green, 3 red.
- NHNKY’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BAX’s TA Score shows that 3 TA indicator(s) are bullish while NHNKY’s TA Score has 4 bullish TA indicator(s).
- BAX’s TA Score: 3 bullish, 4 bearish.
- NHNKY’s TA Score: 4 bullish, 3 bearish.
Price Growth
BAX (@Pharmaceuticals: Other) experienced а -2.43% price change this week, while NHNKY (@Medical/Nursing Services) price change was -1.07% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.76%. For the same industry, the average monthly price growth was +4.59%, and the average quarterly price growth was +33.30%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.84%. For the same industry, the average monthly price growth was +7.29%, and the average quarterly price growth was +29.12%.
Reported Earning Dates
BAX is expected to report earnings on Oct 30, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (-0.76% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (+1.84% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| BAX | NHNKY | BAX / NHNKY | |
| Capitalization | 12.4B | 1.91B | 649% |
| EBITDA | 1.04B | 22.9B | 5% |
| Gain YTD | -15.937 | -19.686 | 81% |
| P/E Ratio | 87.85 | 20.01 | 439% |
| Revenue | 10.9B | 221B | 5% |
| Total Cash | 1.69B | 49.1B | 3% |
| Total Debt | 9.73B | 477M | 2,039% |
BAX | NHNKY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 10 | 23 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 20 Undervalued | 14 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 23 | |
PRICE GROWTH RATING 1..100 | 64 | 64 | |
P/E GROWTH RATING 1..100 | 33 | 71 | |
SEASONALITY SCORE 1..100 | 85 | 37 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NHNKY's Valuation (14) in the null industry is in the same range as BAX (20) in the Medical Specialties industry. This means that NHNKY’s stock grew similarly to BAX’s over the last 12 months.
NHNKY's Profit vs Risk Rating (100) in the null industry is in the same range as BAX (100) in the Medical Specialties industry. This means that NHNKY’s stock grew similarly to BAX’s over the last 12 months.
NHNKY's SMR Rating (23) in the null industry is significantly better than the same rating for BAX (92) in the Medical Specialties industry. This means that NHNKY’s stock grew significantly faster than BAX’s over the last 12 months.
NHNKY's Price Growth Rating (64) in the null industry is in the same range as BAX (64) in the Medical Specialties industry. This means that NHNKY’s stock grew similarly to BAX’s over the last 12 months.
BAX's P/E Growth Rating (33) in the Medical Specialties industry is somewhat better than the same rating for NHNKY (71) in the null industry. This means that BAX’s stock grew somewhat faster than NHNKY’s over the last 12 months.
| BAX | NHNKY | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 61% | N/A |
| Stochastic ODDS (%) | 1 day ago 57% | 1 day ago 60% |
| Momentum ODDS (%) | 1 day ago 68% | 1 day ago 71% |
| MACD ODDS (%) | 1 day ago 52% | 1 day ago 62% |
| TrendWeek ODDS (%) | 1 day ago 60% | 1 day ago 66% |
| TrendMonth ODDS (%) | 1 day ago 57% | 1 day ago 64% |
| Advances ODDS (%) | 5 days ago 52% | 1 day ago 58% |
| Declines ODDS (%) | 7 days ago 60% | 20 days ago 64% |
| BollingerBands ODDS (%) | N/A | 1 day ago 70% |
| Aroon ODDS (%) | 1 day ago 56% | N/A |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VISGX | 83.94 | 0.38 | +0.45% |
| Vanguard Small Cap Growth Index Inv | |||
| FKAIX | 54.51 | 0.22 | +0.41% |
| Federated Hermes Kaufmann Small Cap IS | |||
| AGCVX | 20.96 | 0.05 | +0.24% |
| American Century Global Small Cap Inv | |||
| TAREX | 26.83 | -0.02 | -0.07% |
| Third Avenue Real Estate Value Instl | |||
| MLPAX | 8.27 | -0.05 | -0.60% |
| Invesco SteelPath MLP Alpha A | |||
BAX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BAX has been loosely correlated with ALGN. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if BAX jumps, then ALGN could also see price increases.
| Ticker / NAME | Correlation To BAX | 1D Price Change % | ||
|---|---|---|---|---|
| BAX | 100% | -1.35% | ||
| ALGN - BAX | 60% Loosely correlated | -1.62% | ||
| LUNG - BAX | 53% Loosely correlated | -2.30% | ||
| STE - BAX | 51% Loosely correlated | +1.23% | ||
| SYK - BAX | 51% Loosely correlated | +0.20% | ||
| SOLV - BAX | 50% Loosely correlated | +2.59% | ||
More | ||||
NHNKY and
Correlation & Price change
A.I.dvisor tells us that NHNKY and TRUMY have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NHNKY and TRUMY's prices will move in lockstep.
| Ticker / NAME | Correlation To NHNKY | 1D Price Change % | ||
|---|---|---|---|---|
| NHNKY | 100% | +0.61% | ||
| TRUMY - NHNKY | 25% Poorly correlated | +1.40% | ||
| PSNL - NHNKY | 23% Poorly correlated | +1.53% | ||
| SYK - NHNKY | 22% Poorly correlated | +0.20% | ||
| BAX - NHNKY | 22% Poorly correlated | -1.35% | ||
| QGEN - NHNKY | 21% Poorly correlated | +0.06% | ||
More | ||||